Northern Trust
PHIO icon

Northern Trust’s Phio Pharmaceuticals PHIO Stock Holding History

Northern Trust’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29K Hold
23,758
– – ﹤0.01% 4310
2025
Q4 		$24.9K Buy
+23,758
New +$38K ﹤0.01% 4372
2018
Q1 		– Hold
0
– -$7K – 4273
2017
Q4 		– Hold
0
– – – 4205
2017
Q3 		– Hold
0
– – – 4217
2017
Q2 		– Hold
0
– – – 4234
2017
Q1 		– Hold
0
– – – 4200
2016
Q2 		– Hold
0
– -$3K – 4258
2016
Q1 		– Hold
0
– – – 4215
2015
Q4 		– Hold
0
– – – 4235
2015
Q3 		– Hold
0
– – – 4247
2015
Q2 		– Hold
0
– – – 4194
2015
Q1 		– Hold
0
– – – 4259
2014
Q4 		– Hold
0
– – – 4166
2014
Q3 		– Hold
0
– – – 4185
2014
Q2 		– Hold
0
– – – 4119
2014
Q1 		– Hold
0
– – – 4016

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Northern Trust's PHIO Position: Q1 2026 in Review

Northern Trust held its Phio Pharmaceuticals (PHIO) position steady in Q1 2026 at 23,758 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #4310.

Northern Trust first reported a position in PHIO in Q4 2025 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Northern Trust held 23,758 shares of Phio Pharmaceuticals worth $29K as of Q1 2026.
  • Northern Trust left its Phio Pharmaceuticals share count unchanged in Q1 2026.
  • Phio Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4310 holding.
  • Northern Trust first reported a position in Phio Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.